Sunjeet Sawhney
Directeur Général chez Rappta Therapeutics Oy
Postes actifs de Sunjeet Sawhney
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Rappta Therapeutics Oy
 Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Directeur Général | 15/09/2021 | - |
Historique de carrière de Sunjeet Sawhney
Formation de Sunjeet Sawhney
| University of London | Graduate Degree |
Statistiques
Internationale
| Finlande | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Chief Executive Officer | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Rappta Therapeutics Oy
Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Health Technology |
- Bourse
- Insiders
- Sunjeet Sawhney
- Expérience
